Dingwei Zhao to Androgen Antagonists
This is a "connection" page, showing publications Dingwei Zhao has written about Androgen Antagonists.
Connection Strength
0.215
-
CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors. Nat Cancer. 2025 May; 6(5):854-873.
Score: 0.215